Searched for
RUBICON
Ahead of Market: 10 things that will decide stock market action on FridayIndian benchmark indices ended slightly lower amid weakness in FMCG, IT and banking stocks, while analysts highlighted improving technical ...- Rubicon Research shares can rally 22%, says Motilal Oswal after initiating with ‘Buy’ ratingShares of Rubicon Research rose up to 3% on October 31 after Motilal Oswal initiated coverage with a ‘Buy’ rating and a target price of Rs ...
- Healthy start! Rubicon Research shares list at 28% premium over IPO priceRubicon Research Share Price debuted on stock exchanges with a significant 27.9% premium, opening at Rs 620. The Rs 1,377 crore IPO saw ove...
- Rubicon Research IPO allotment date today: GMP at Rs 95; How to check status on BSE and MUFG IntimeRubicon Research IPO Allotment Status: Rubicon Research's Rs 1,377 crore IPO concluded with strong investor demand, oversubscribing 109.35 ...
- Rubicon Research IPO Day 3: GMP, subscription status, brokerage views, and key highlightsRubicon Research’s IPO, backed by Arihant Capital with a “Subscribe” rating, highlights the company’s strong growth and diversified pharma ...
- Rubicon Research IPO Day 2: Issue booked 2.37 times. Check GMP, other detailsRubicon Research's IPO saw strong investor demand, subscribed 2.37 times. The pharma firm specializes in generics and specialty drugs. Its ...
- Rubicon Research IPO Day 1: Subscribed 51% in initial hours – Check GMP, Brokerages' views, and key detailsRubicon Research IPO: Rubicon Research is trading at a grey market premium of ₹90, roughly 19% above the upper price band, reflecting stron...
- Rubicon Research IPO: Check GMP, brokerages review, subscription and other detailsRubicon Research's Rs 1,377 crore IPO opens on October 9. The specialty and generics pharmaceutical manufacturer offers shares at Rs 461-48...
- TIMF Holdings, 360 ONE Funds invest Rs 140 cr in Rubicon Research ahead of IPORubicon Research secured Rs 140 crore from TIMF Holdings and 360 ONE funds before its IPO. General Atlantic Singapore RR Pte transferred sh...
- Amansa Investments pumps Rs 250 cr in Rubicon Research in pre-IPO funding round; issue by year-endAmansa Investments Ltd has invested Rs 250 crore in pharma formulation firm Rubicon Research Ltd through a pre-initial public offering (IPO...
- Alkem Laboratories to sell Pithampur unit for Rs 149 croreAlkem Laboratories Ltd agrees to sell its manufacturing facility in Pithampur, Madhya Pradesh, to Rubicon Research Ltd for Rs 149 crore via...
- Rubicon Research files DRHP for Rs 1,085 crore IPORubicon Research IPO News: The company’s IPO comprises a fresh issue of up to ₹500 crore and an offer for sale of up to ₹ 585 crore by the ...
- Rubicon, apna.co partner to enable 50,000+ job opportunities in FY25apna.co partners with Rubicon to empower job seekers with essential skills. Nirmit Parikh, Founder & CEO, and Dhanya Narayanan, COO of Rubi...
- Rubicon Research acquires Satara facility of Meditab SpecialitiesWithout disclosing the deal size, Rubicon Research said the Satara facility is cGMP compliant and MHRA (UK)-inspected production site.
- Everstone to sell entire stake in Rubicon Research for Rs 1,000 croreIn 2016, Everstone Group acquired 70 per cent shareholding in Rubicon for about Rs 220 crore.
- General Atlantic to acquire Rubicon as Everstone Cap exitsThe acquisition would mark General Atlantic’s renewed focus on pharma, the buyout major having also backed Jubilant Lifesciences.
- Everstone Capital invests Rs 220 crore in Rubicon ResearchThe $33 million investment, which has both, primary and secondary components, will also provide Kotak Private Equity, an early investor in ...
- Everstone Capital invests Rs 220-cr in RubiconEvertsone Capital, a mid-market equity firm, is stepping up its deal-making pace and with this investment in Rubicon, a contract research a...
- Everstone buys Mumbai-based drug tech firm Rubicon for Rs 220-croreThe India and Southeast Asia-focused Everstone has assets under management of USD3.3 billion and is headquartered in Singapore.
- Kotak PE invests in Rubicon ResearchKotak Private Equity said on Tuesday that it has invested in Rubicon Research, a product development company.
Load More
